Harbin Pharmaceutical Group Co., Ltd. (600664.SS) SHH

3.72

+0(+0.00%)

Updated at December 05 11:29AM

Currency In CNY

Valuation

Market Cap10.39B
Enterprise Value8.38B
P/E Ratio20.86
PEG Ratio-1.1
Price/Sales Ratio0.59
Price/Book Ratio1.66
Enterprise/Revenue0.59
Enterprise/EBITDA11.53

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.03
Operating Margin0.04

Management Effectiveness

Return On Assets0.03
Return On Equity0.08

Income Statement

Revenue16.18B
Revenue/Share6.33
Gross Profit4.52B
EBITDA1.07B
Net Income628.85M
Diluted EPS0.25

Balance Sheet

Total Cash2.74B
Total Cash/Share1.09
Total Debt2.76B
Total Debt/Equity0.49
Current Ratio1.44
Book Value Per Share2.54

Price History

52-Week Change-4.86
52-Week High4.97
52-Week Low3.06
Moving Average 50 Days3.66
Moving Average 200 Days3.72

Statistics

Average Volume39.76M
Shares Outstanding2.52B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.03
Last Split Factor13:10
Last Split DateApril 06, 2016